Phase III, randomized, double-blind, placebo-controlled study of modafinil for fatigue in patients treated with docetaxel-based chemotherapy

被引：0

作者：

Elizabeth Hovey

Paul de Souza

Gavin Marx

Phillip Parente

Tal Rapke

Andrew Hill

Antonino Bonaventura

Antony Michele

Paul Craft

Ehtesham Abdi

Andrew Lloyd

机构：

[1] Prince of Wales Hospital,Department of Medical Oncology

[2] University of New South Wales,undefined

[3] University of Western Sydney,undefined

[4] Sydney Haematology Oncology Clinics,undefined

[5] Box Hill Hospital,undefined

[6] Sanofi Australia Pty Ltd,undefined

[7] Gold Coast Hospital,undefined

[8] ANZGOG,undefined

[9] Calvary Hospital,undefined

[10] The Canberra Hospital,undefined

[11] The Tweed Hospital,undefined

[12] Griffith University,undefined

来源：

Supportive Care in Cancer | 2014年 / 22卷

关键词：

Breast cancer; Docetaxel; Fatigue; Prostate cancer; Modafinil; Chemotherapy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1233 / 1242

页数：9

共 50 条

[31] Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphamide chemotherapy
Kosaka, Yoshimasa
Rai, Yoshiaki
Masuda, Norikazu
Takano, Toshimi
Saeki, Toshiaki
Nakamura, Seigo
Shimazaki, Ryutaro
Ito, Yoshinori
Tokuda, Yutaka
Tamura, Kazuo
SUPPORTIVE CARE IN CANCER, 2015, 23 (04) : 1137 - 1143
[32] Ondansetron in patients with tinnitus: randomized double-blind placebo-controlled study
Taslimi, Shervin
Vahidi, Hamed
Pourvaziri, Ali
Modabbernia, Amirhossein
Fallah, Arezoo Yeke
Yazdani, Nasrin
Taslimi, Negin
Hosseini, Mostafa
Zarandi, Masoud Motesadi
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2013, 270 (05) : 1635 - 1641
[33] Ondansetron in patients with tinnitus: randomized double-blind placebo-controlled study
Shervin Taslimi
Hamed Vahidi
Ali Pourvaziri
Amirhossein Modabbernia
Arezoo Yeke Fallah
Nasrin Yazdani
Negin Taslimi
Mostafa Hosseini
Masoud Motesadi Zarandi
European Archives of Oto-Rhino-Laryngology, 2013, 270 : 1635 - 1641
[34] A double-blind, placebo-controlled trial of modafinil for cocaine dependence
Dackis, Charles A.
Kampman, Kyle M.
Lynch, Kevin G.
Plebani, Jennifer G.
Pettinati, Helen M.
Sparkman, Thorne
O'Brien, Charles P.
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2012, 43 (03) : 303 - 312
[35] Re: Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy
VanAudenrode, M
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (10) : 761 - 762
[36] Antithrombin III in patients with severe sepsis - A multinational, double-blind, randomized, placebo-controlled phase-III study.
Opal, S
Heinrichs, H
Mescheder, A
Keinecke, HO
Knaub, S
BLOOD, 1998, 92 (10) : 108B - 108B
[37] A double-blind, placebo-controlled trial of modafinil in cocaine dependence
Dackis, CA
Kampman, KM
Lynch, KG
Pettinati, HM
Klein, LJ
McAllister, MH
Smith, KJ
O'Brien, CP
NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S72 - S73
[38] A Double-Blind, Placebo-Controlled Trial of Modafinil for Cocaine Dependence
Charles A Dackis
Kyle M Kampman
Kevin G Lynch
Helen M Pettinati
Charles P O'Brien
Neuropsychopharmacology, 2005, 30 : 205 - 211
[39] A double-blind, placebo-controlled trial of modafinil for cocaine dependence
Dackis, CA
Kampman, KM
Lynch, KG
Pettinati, HM
O'Brien, CP
NEUROPSYCHOPHARMACOLOGY, 2005, 30 (01) : 205 - 211
[40] A phase III double-blind placebo-controlled randomized study of dexamphetamine sulfate for fatigue in primary brain tumors patients: An ANOCEF trial (DXA)
Laigle-Donadey, Florence
Ducray, Francois
Boone, Matthieu
Diallo, Mamadou Hassimiou
Hajage, David
Ramirez, Carole
Chinot, Olivier
Ricard, Damien
Delattre, Jean-Yves
NEURO-ONCOLOGY ADVANCES, 2019, 1 (01)

← 1 2 3 4 5 →